Volpara Health Technologies announced the following changes to its Board of Directors to further enhance the Board's expertise around patient data and US healthcare networks and drive the Company's best-practice governance standards. Highly experienced senior healthcare general manager and finance executive Ann Custin joins the Board as an independent, Non-Executive Director, effective 1 September 2021. Ann brings a deep network of industry contacts from an extensive career in healthcare across Europe, the Americas, and Asia. Her most recent executive role was with Siemens Healthineers, where she served as both CFO and board director of Siemens Medical Solutions. Prior to this Ann served as chief operating and financial officer of Scient'x and President & CEO of USA Draeger Medical Systems Inc. Ann is also a Non-Executive Director of NASDAQ-listed Establishment Labs Holdings Inc., a medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, that has a market capitalisation of approximately US$1.7 billion. The Company also announces that Non-Executive Director Dr. Monica Saini has retired from the Volpara Board of Directors, effective 18 August 2021, as she focuses her efforts on direct patien care and health advocacy through her private breast cancer screening practice. Monica will remain closely linked to Volpara, using its products and providing input into future product development.